Elevated Ki-67 expression may predict progression to cancer in some precursor lesions (Shaaban et al, 2002); in DCIS, high Ki-67 expression levels may predict in situ or invasive recurrence (Simpson et al, 2007). This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.